Maes, K.; Menu, E.; Van Valckenborgh, E.; Van Riet, I.; Vanderkerken, K.; De Bruyne, E.
Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma. Cancers 2013, 5, 430-461.
https://doi.org/10.3390/cancers5020430
AMA Style
Maes K, Menu E, Van Valckenborgh E, Van Riet I, Vanderkerken K, De Bruyne E.
Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma. Cancers. 2013; 5(2):430-461.
https://doi.org/10.3390/cancers5020430
Chicago/Turabian Style
Maes, Ken, Eline Menu, Els Van Valckenborgh, Ivan Van Riet, Karin Vanderkerken, and Elke De Bruyne.
2013. "Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma" Cancers 5, no. 2: 430-461.
https://doi.org/10.3390/cancers5020430
APA Style
Maes, K., Menu, E., Van Valckenborgh, E., Van Riet, I., Vanderkerken, K., & De Bruyne, E.
(2013). Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma. Cancers, 5(2), 430-461.
https://doi.org/10.3390/cancers5020430